Old Well Partners LLC bought a new position in Janux Therapeutics, Inc. (NASDAQ:JANX – Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 10,300 shares of the company’s stock, valued at approximately $104,000. Several other hedge funds and […]
Old Well Partners LLC bought a new stake in Janux Therapeutics, Inc. (NASDAQ:JANX – Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 10,300 shares of the company’s stock, valued at approximately $104,000. Several other hedge funds and other institutional […]
Janux Therapeutics (NASDAQ:JANX – Get Free Report)‘s stock had its “outperform” rating reissued by equities researchers at William Blair in a report issued on Tuesday, RTT News reports. JANX has been the subject of several other research reports. HC Wainwright reissued a “buy” rating and issued a $35.00 target price on shares of Janux Therapeutics […]
Janux Therapeutics (NASDAQ:JANX – Get Free Report) had its target price hoisted by Wedbush from $24.00 to $53.00 in a research report issued to clients and investors on Tuesday, Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Wedbush’s price objective would indicate a potential upside of 250.99% from the company’s current […]
Janux Therapeutics (NASDAQ:JANX – Get Free Report) had its price target hoisted by Wedbush from $24.00 to $53.00 in a report released on Tuesday, Benzinga reports. The firm presently has an “outperform” rating on the stock. Wedbush’s target price would suggest a potential upside of 250.99% from the company’s previous close. Separately, HC Wainwright reiterated […]